Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification
-
- Nehal A. Kasim
- College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065, College of Pharmacy, University of Alexandria, Alexandria, Egypt, Department of Pharmacy and Technology, University of Valencia, Valencia, Spain, Department of Pharmacy, BMC, Uppsala University, SE-751 23 Uppsala, Sweden, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Food and Drug Administration, Rockville, Maryland 20857, Division of Pharmaceutical Technology, Leiden/Amsterdam Center for Drug...
-
- Marc Whitehouse
- College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065, College of Pharmacy, University of Alexandria, Alexandria, Egypt, Department of Pharmacy and Technology, University of Valencia, Valencia, Spain, Department of Pharmacy, BMC, Uppsala University, SE-751 23 Uppsala, Sweden, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Food and Drug Administration, Rockville, Maryland 20857, Division of Pharmaceutical Technology, Leiden/Amsterdam Center for Drug...
-
- Chandrasekharan Ramachandran
- College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065, College of Pharmacy, University of Alexandria, Alexandria, Egypt, Department of Pharmacy and Technology, University of Valencia, Valencia, Spain, Department of Pharmacy, BMC, Uppsala University, SE-751 23 Uppsala, Sweden, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Food and Drug Administration, Rockville, Maryland 20857, Division of Pharmaceutical Technology, Leiden/Amsterdam Center for Drug...
-
- Marival Bermejo
- College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065, College of Pharmacy, University of Alexandria, Alexandria, Egypt, Department of Pharmacy and Technology, University of Valencia, Valencia, Spain, Department of Pharmacy, BMC, Uppsala University, SE-751 23 Uppsala, Sweden, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Food and Drug Administration, Rockville, Maryland 20857, Division of Pharmaceutical Technology, Leiden/Amsterdam Center for Drug...
-
- Hans Lennernäs
- College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065, College of Pharmacy, University of Alexandria, Alexandria, Egypt, Department of Pharmacy and Technology, University of Valencia, Valencia, Spain, Department of Pharmacy, BMC, Uppsala University, SE-751 23 Uppsala, Sweden, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Food and Drug Administration, Rockville, Maryland 20857, Division of Pharmaceutical Technology, Leiden/Amsterdam Center for Drug...
-
- Ajaz S. Hussain
- College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065, College of Pharmacy, University of Alexandria, Alexandria, Egypt, Department of Pharmacy and Technology, University of Valencia, Valencia, Spain, Department of Pharmacy, BMC, Uppsala University, SE-751 23 Uppsala, Sweden, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Food and Drug Administration, Rockville, Maryland 20857, Division of Pharmaceutical Technology, Leiden/Amsterdam Center for Drug...
-
- Hans E. Junginger
- College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065, College of Pharmacy, University of Alexandria, Alexandria, Egypt, Department of Pharmacy and Technology, University of Valencia, Valencia, Spain, Department of Pharmacy, BMC, Uppsala University, SE-751 23 Uppsala, Sweden, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Food and Drug Administration, Rockville, Maryland 20857, Division of Pharmaceutical Technology, Leiden/Amsterdam Center for Drug...
-
- Salomon A. Stavchansky
- College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065, College of Pharmacy, University of Alexandria, Alexandria, Egypt, Department of Pharmacy and Technology, University of Valencia, Valencia, Spain, Department of Pharmacy, BMC, Uppsala University, SE-751 23 Uppsala, Sweden, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Food and Drug Administration, Rockville, Maryland 20857, Division of Pharmaceutical Technology, Leiden/Amsterdam Center for Drug...
-
- Kamal K. Midha
- College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065, College of Pharmacy, University of Alexandria, Alexandria, Egypt, Department of Pharmacy and Technology, University of Valencia, Valencia, Spain, Department of Pharmacy, BMC, Uppsala University, SE-751 23 Uppsala, Sweden, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Food and Drug Administration, Rockville, Maryland 20857, Division of Pharmaceutical Technology, Leiden/Amsterdam Center for Drug...
-
- Vinod P. Shah
- College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065, College of Pharmacy, University of Alexandria, Alexandria, Egypt, Department of Pharmacy and Technology, University of Valencia, Valencia, Spain, Department of Pharmacy, BMC, Uppsala University, SE-751 23 Uppsala, Sweden, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Food and Drug Administration, Rockville, Maryland 20857, Division of Pharmaceutical Technology, Leiden/Amsterdam Center for Drug...
-
- Gordon L. Amidon
- College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065, College of Pharmacy, University of Alexandria, Alexandria, Egypt, Department of Pharmacy and Technology, University of Valencia, Valencia, Spain, Department of Pharmacy, BMC, Uppsala University, SE-751 23 Uppsala, Sweden, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Food and Drug Administration, Rockville, Maryland 20857, Division of Pharmaceutical Technology, Leiden/Amsterdam Center for Drug...
書誌事項
- 公開日
- 2003-12-17
- DOI
-
- 10.1021/mp034006h
- 公開者
- American Chemical Society (ACS)
この論文をさがす
収録刊行物
-
- Molecular Pharmaceutics
-
Molecular Pharmaceutics 1 (1), 85-96, 2003-12-17
American Chemical Society (ACS)